4//SEC Filing
Rozenman Mary M. 4
Accession 0000899243-18-000456
CIK 0001631650other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:05 PM ET
Size
11.8 KB
Accession
0000899243-18-000456
Insider Transaction Report
Form 4
Rozenman Mary M.
See Remarks
Transactions
- Sale
Common Stock, $0.0001 par value
2018-01-02$37.12/sh−4,990$185,223→ 1,730 total - Sale
Common Stock, $0.0001 par value
2018-01-02$37.08/sh−1,601$59,367→ 129 total - Exercise/Conversion
Common Stock, $0.0001 par value
2018-01-02$3.02/sh+6,591$19,918→ 6,720 total - Exercise/Conversion
Stock Option (right to buy)
2018-01-02−6,591→ 113,835 totalExercise: $3.02Exp: 2025-04-17→ Common Stock (6,591 underlying)
Footnotes (4)
- [F1]The sales reported in the Form 4 were effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $36.65 to $37.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The transaction was executed in multiple trades in prices ranging from $36.69 to $37.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F4]The option is immediately exercisable in full or in part. The shares vest pursuant to the following schedule: Twenty Five Percent (25%) of the shares subject to the option vest on the first anniversary measured from February 1, 2015 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001648920
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:05 PM ET
- Size
- 11.8 KB